Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 2 , ISSUE 2 ( April-June, 2018 ) > List of Articles

RESEARCH ARTICLE

Clinical Efficacy/Safety of Therapeutic Combination; Kshirbala Taila Matra Basti, Vatari Guggulu, Maharasnadi Kwatha and Narayan Taila in the Management of Osteoarthritis Knee (Sandhivata): A Prospective Open Label Study

UR Sekhar Namburi, Bharti

Keywords : , Kshirbala Taila, Maharasnadi Kwatha, Matra Basti, Narayana Taila, OA knee, Sandhivata, Vatari Guggulu, WOMAC Score,Global assessment of disease activity score

Citation Information : Namburi US, B. Clinical Efficacy/Safety of Therapeutic Combination; Kshirbala Taila Matra Basti, Vatari Guggulu, Maharasnadi Kwatha and Narayan Taila in the Management of Osteoarthritis Knee (Sandhivata): A Prospective Open Label Study. J Res Ayurvedic Sci 2018; 2 (2):90-98.

DOI: 10.5005/jp-journals-10064-0044

License: CC BY-NC 3.0

Published Online: 00-06-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Osteoarthritis (OA) knee is the most frequent joint disease encountered in the clinical practice and a leading cause of disability in the elderly. It is a chronic degenerative disorder of multi-factorial etiology characterized by loss of articular cartilage, hypertrophy of bone at the margins, subchondral sclerosis and range of biochemical and morphological alterations of the synovial membrane and joint capsule. The clinical presentation of OA is similar to Sandhivata described under Vatavyadhi in Ayurveda. Objectives: To evaluate the clinical efficacy and safety of Kshirbala Taila Matra Basti chikitsa along with Vatari Guggulu, Maharasnadi Kwatha internally and local application of Narayan Taila in the management of OA knee. Materials and Methods: A prospective, interventional, openlabel study was carried out at the Regional Aryuveda Research Institute for Mother and Child Health (RARIMCH), Nagpur. Sixty patients in the age group 35-65 years with primary OA of knee joint fulfilling the diagnostic criteria were enrolled. A combination of Kshirbala Taila Matra Basti for 27 days in three courses (each of 9 days) along with Vatari Guggulu, Maharasnadi Kwatha orally and local application of Narayan Taila locally, was administered for 12 weeks. Subjects were followed every fortnightly during treatment and after 4 weeks of completion of treatment. Assessment was done at every two weeks on the basis of the change in pain, stiffness and physical function using the validated modified western ontario and McMster Universities osteoartharitis index (WOMAC) questionnaire, visual analog scale (VAS) scale and global Assessment of disease activity scale. Observations and Results: A significant reduction in total WOMAC score (p-value < 0.001) was observed after the treatment of 12 weeks and also at the end of 16th week. The mean knee joint pain score assessed on VAS was 8.05 which reduced significantly to 5.52 on 84th day and 5.37 on follow-up (p < 0.001). The mean score of global assessment of disease activity at baseline was 80.17, which reduced to 51.17 on 84th day and 49.00 on follow up (p < 0.001). No adverse events were reported during the course of treatment. Conclusion: The therapeutic regimen Kshirabala Taila, Matra Basti and Vatari Guggulu, Maharasnadi Kwatha along with topical application of Narayana Taila is safe and significantly effective (P < 0.001) in all the cardinal symptoms of OA of knee joint.


PDF Share
  1. Di Cesare P, Abramson S, Samuels J. Pathogenesis of osteoarthritis. In: Firestein GS, Kelley WN, eds. Kelley's Textbook of Rheumatology; 8th ed. Philadelphia, Pa.: Saunders Elsevier; 2009;1525-1540.
  2. Chopra A, Patil J, Bilampelly V. The Bhigwan (India) COPCORD: Methodology and first information report, APLAR. J Rheumatol 1997;1:145-154.
  3. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW, Cluzeau F, Cooper C, Dieppe PA, Günther KP et. al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000 Dec;59(12):936-944.
  4. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA. Identification of patients at risk for gastropathy associated with NSAID use. J Rheumatol. 1990;20(Suppl):12-19.
  5. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, Moskowitz RW, Schnitzer TJ. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Send to Arthritis Rheum. 1995 Nov;38(11):1541.
  6. Soeken KL, Miller SA, Ernst E. Herbal medicines for the treatment of rheumatoid arthritis: A systematic review. Rheumatology (Oxford). 2003;42(5):652-659.
  7. Engel LW, Straus SE. Development of therapeutics: opportunities within complementary and alternative medicine. Nat Rev Drug Discov. 2002;1(3):229-237.
  8. Charaka, Charaka Samhita, Chikitsasthana, Vatavyadhi Chikitsitam 28/37, Edited by Priyavat Sharma, 1st Edition, Varanasi: Chaukhambha Orientalia Publishers; 2008; 463-464
  9. Vagbhata, Ashtang Hriday, Sutrasthana, Bastividhi Adhyaya 19/1, Edited By Pt. Hari Sadasiva Shastri Pradakara, with commentary of Sarvangsundara by Arundatta and Ayurved Rasayana by Hemadri, Varanasi, Chaukhambha Sanskrit Sansthan,, 2009; 270
  10. Charaka, Charaka Samhita, Siddhisthana, Snehavyapatsiddhi Adhyaya 4/52-54, Edited by Priyavat Sharma, 1st Edition, Varanasi: Chaukhambha Orientalia Publishers; 2008; 619
  11. Vagbhata, Ashtang Hriday, Chikitsasthana, Vatashonitchikitsitam Adhyaya 22/44-45 Edited by Pt. Hari Sadasiva Shastri Pradakara, with commentary of Sarvangsundara by Arundatta and Ayurved Rasayana by Hemadri, Varanasi, Chaukhambha Sanskrit Sansthan,, 2009; 731-732
  12. Govind Das, Bhaishajya Ratnavali, Amavatadhikar, shlok no 152-155, Ed. By Ambikadatta Shastri, Chaukhamba Sanskrit Sansthan, Varanasi, 1983; 443.
  13. Sharangdhara, Sharangadhara Samhita, Madhyam Khanda 2/ 91-93, edited by Shri Dayasankar Pandeya, Varanasi, Chaukhamba Amarbharti Prakashan, 1981: 159
  14. Govind Das, Bhaishajya Ratnavali, Vatavyadhyadhikara, shlok no 332-337, Ed. By Ambikadatta Shastri, Chaukhamba Sanskrit Sansthan, Varanasi, 1983; 396
  15. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors, Harrison's Principle of Internal Medicine, 16th edition. New Delhi: Tata MC Graw Ltd; 2000; 2036-2037.
  16. Oldenhave A, Jaszmann LJ, Haspels AA, Everaerd WT. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 1993;168:772-780.
  17. Lindsay R. Estrogen deficiency. In: Riggs BL, Melton, editors. Osteoporosis: Eetiology, Diagnosis and Management. 2nd ed. Philadelphia: Lippincott-Raven; 1995; 133-160.
  18. Kritz-Silverstein D, Barrett-Connor E. Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health 1993; 83:983-8.
  19. Richa, Sharam S, Sharma ML. Phytochemical Investigations and Anatomical Study of three Species of Sida. Biolife 2014;(2)2:622-629.
  20. Kanth VR, Diwan PV. Analgesic, anti-inflammatory and hypoglycemic activities of Sida cordifolia. Phytother Res. 1999;13(1):75-77.
  21. Franzotti EM, Santos CV, Rodrigues HM, Mourão RH, Andrade MR, Antoniolli AR. Anti-inflammatory, analgesic activity and acute toxicity of Sida cordifolia L. (Malva- Branca). J Ethnopharmacol. 2000;72(1-2):273-277.
  22. Yusuf M, Kabir M. Medicinal plants of Bangladesh. Dhaka: Bangladesh Council of Scientific and Industrial Research (BCSIR); 1999; 226.
  23. Arora RB Taneja V, Sharma RC. Anti-inflammatory studies on a crystalline steroid isolated from commifora mukul. Ind J Med Res. 1972;60(6):929-931.
  24. Singh BB, Mishra LC, Vinjamury SP, Aquilina N, Singh VJ, Shepard N. The effectiveness of commifora mukul for osteoarthritis of knee: an outcome study. Altern Ther Health Med. 2003;9(3):74-9.
  25. Vieira C, Evangelista S, Cirillo R, Lippi A, Maggi CA, Manzini S. Effect of ricinoleic acid in acute and sub chronic experimental models of inflammation. Mediators Inflamm. 2000;9(5):223-8.
  26. Shrivastawa V, Varma N, Tandon JS, Srimal RC. Anti-Inflammatory Activity of Pluchea lanceolata: Isolation of an Active Principle. Int J Crude Drug Res.1990;28(2):135-7.
  27. Ahmad F, Khan RA, Rashid S. Pharmacological Evaluation of Medicinal Plants for Their Analgesic Activity in Mice. Medical Journal of the Islamic Republic of Iran 1996;10(2):149- 52.
  28. Thabrew MI, Dharmasiri MG, Senaratne L. Anti-inflammatory and analgesic activity in the polyherbal formulation maharasnadi quatha. J Ethnopharmacol. 2003;85(2-3): 261-7.
  29. Patil S, Kanase R, Kulkarni PH. Studies on anti-inflammatory actions of Sinhanad Guggulu and Narayan Tail in albino rats. Kulkarni PH(Ed.) (1999b.);2001; 5-12.
PDF Share